Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Warfarin-griseofulvin interaction.

K Okino, R T Weibert

    Drug Intelligence & Clinical Pharmacy
    |April 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Griseofulvin can significantly decrease the effectiveness of warfarin, requiring dose adjustments. Close monitoring of prothrombin time is essential when these medications are used together.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Control of the thermal lensing effect with different pump light distributions.

    Applied optics·2008
    Same author

    Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
    Same author

    Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries.

    Kidney international·2006
    Same author

    A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation.

    The Annals of pharmacotherapy·2000
    Same author

    Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.

    The Journal of pathology·1998
    Same author

    Correction of excessive anticoagulation with low-dose oral vitamin K1.

    Annals of internal medicine·1997
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Drug Interactions

    Background:

    • Warfarin is a commonly prescribed anticoagulant for patients with mechanical heart valves.
    • Therapeutic anticoagulation with warfarin requires careful monitoring of prothrombin time (PT).

    Observation:

    • A patient on long-term warfarin therapy experienced reduced anticoagulation after initiating griseofulvin.
    • A 41% increase in warfarin dosage was necessary to maintain therapeutic levels.
    • Decreasing griseofulvin dosage led to increased PT and a subsequent reduction in warfarin dose.

    Findings:

    • Griseofulvin significantly diminishes the therapeutic response to warfarin.
    • This interaction necessitates careful dose titration of warfarin when co-administered with griseofulvin.

    Implications:

    Related Experiment Videos

    • Clinicians should be aware of the potential for griseofulvin to reduce warfarin efficacy.
    • Regular PT monitoring and warfarin dose adjustments are crucial for patients receiving both medications.
    • Prompt recognition and management of this drug interaction can prevent thromboembolic events.